Previous 10 | Next 10 |
BioIQ and DermTech Enter into an Agreement to Add Non-invasive DermTech Melanoma Test to BioIQ's Health Testing Solution Lineup Integrated telehealth consultations and consumer-friendly testing options help health plans, employers, and government entities execute population heal...
We review 5 top stock ideas that have been created by the Fed’s tomfoolery (3 are pure-growth stocks and 2 are dividend-growth stocks). We also discuss a big reason why cryptocurrency popularity continues to grow (hint: more Fed tomfoolery). We conclude with our opinion on ...
Dermtech (NASDAQ: DMTK) is an upstart healthcare company that's revolutionizing the way skin care is detected -- with a simple patch rather than a biopsy. In this segment of "The 5," recorded on Nov. 23 , Fool contributors Connor Allen and Jason Hall discuss Dermtech...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the expansion and branding of its translational medicine service offering, DermTech Stratum...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its session presentation, focused on non-invasive precision dermatology approaches, at the fifth annual Dermatology Drug D...
The following slide deck was published by DermTech, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: DermTech, Inc. 2021 Q3 - Results - Earnings Call Presentation
If you are looking to invest in companies that aim to provide disruptive technology to the healthcare sector, there can be plenty of intriguing options. While some of those may lack a solid foundation to build a high-quality business on, 10x Genomics (NASDAQ: TXG) and DermTech ...
AerSale (NASDAQ:ASLE) -36% on Q3 earnings release. Purple Innovation (NASDAQ:PRPL) -32% on Q3 earnings release. Poshmark (NASDAQ:POSH) -30% on Q3 earnings release. Upstart Holdings (NASDAQ:UPST) -23% on Q3 earnings release. AnPac Bio-Medical S...
DermTech, Inc. (DMTK) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Dobak - President and Chief Executive Officer Kevin Sun - Chief Financial Officer Conference Call Participants Brian Weinstein - William Blair Max ...
Shares of DermTech (NASDAQ:DMTK) are down 14% in after-hours trading after its Q3 2021 results missed on both EPS and revenue and it revised its full-year revenue outlook. The company now estimates full-year assay revenue of $10.5M-$12M. Consensus is $13.3M. Almost all of DermT...